UMIN-CTR History

Name:  UMIN ID:


Unique ID issued by UMIN UMIN000010027
Receipt number R000011740
Scientific Title Phase I/II clinical study of WT4869 peptide-based immunotherapy in patients with completely resected stage IA with vascular invasion, stage IB and stage II non-small cell lung cancer with WT1 antigen positive.
Date of disclosure of the study information 2013/02/13
Last modified on 2015/07/13 19:56:52

No. Disposal Last modified on Item of update
1 Insert 2013/02/13 18:09:08
2 Update 2013/02/15 14:23:10 Recruitment status
3 Update 2013/08/22 17:53:48 Key inclusion criteria
Key inclusion criteria
Key exclusion criteria
4 Update 2013/08/22 18:15:23 TEL
Email
Email
Email
5 Update 2013/08/22 18:24:38 Key exclusion criteria
6 Update 2013/08/22 18:45:17 Key inclusion criteria
7 Update 2014/03/13 10:15:56 Key inclusion criteria
8 Update 2014/08/14 11:32:30 Recruitment status
9 Update 2015/03/13 09:22:04 Organization
Organization
Category of Funding Organization
10 Update 2015/07/13 19:56:53 Recruitment status
Last follow-up date
Date of closure to data entry
Date trial data considered complete